Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Complex regional pain syndrome type 2 (CRPS2), or causalgia is a form of complex regional pain syndrome that develops after damage to a peripheral nerve and is characterized by spontaneous pain, allodynia and hyperalgesia, not necessarily limited to the territory of the injured nerve, as well as at some point, edema, changes in skin blood flow or sudomotor dysfunction in the pain area.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE4. Research is primarily sponsored by academic and government institutions.
12 publications have been identified in PubMed for complex regional pain syndrome type 2. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (25%), and Clinical Trial Publication (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 4:31 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 3 | 25% |
Clinical study results | 2 | 17% |
Disease patterns and progression | 1 | 8% |
Watson CPN (2026). [PMID: 40788267](https://pubmed.ncbi.nlm.nih.gov/40788267/). *Pain*. [Case Report / Case Series]
Perle SJ (2026). [PMID: 42064011](https://pubmed.ncbi.nlm.nih.gov/42064011/). *J Hand Surg Glob Online*. [Epidemiology / Natural History]
Gouveia JF (2025). [PMID: 41362538](https://pubmed.ncbi.nlm.nih.gov/41362538/). *Cureus*. [Case Report / Case Series]
Kim DC (2025). [PMID: 39440391](https://pubmed.ncbi.nlm.nih.gov/39440391/). *Pain Pract*. [Case Report / Case Series]
Ruviaro NA (2025). [PMID: 40383737](https://pubmed.ncbi.nlm.nih.gov/40383737/). *Mol Neurobiol*. [Review / Meta-Analysis]
Alzarah MA (2025). [PMID: 41031866](https://pubmed.ncbi.nlm.nih.gov/41031866/). *Pain Med Case Rep*. [Case Report / Case Series]
Stegeman M (2024). [PMID: 39656213](https://pubmed.ncbi.nlm.nih.gov/39656213/). *Acta Orthop*. [Clinical Trial Publication]
Özdemir EC (2024). [PMID: 39318174](https://pubmed.ncbi.nlm.nih.gov/39318174/). *J Rehabil Med*. [Clinical Trial Publication]
Maria Frare J (2024). [PMID: 39182734](https://pubmed.ncbi.nlm.nih.gov/39182734/). *Biochem Pharmacol*. [Review / Meta-Analysis]
Her YF (2024). [PMID: 39220373](https://pubmed.ncbi.nlm.nih.gov/39220373/). *Int Med Case Rep J*. [Case Report / Case Series]